All U.S. study centers have started administering treatment in clinical trials for erythropoietic protoporphyria (EPP) and word is the EPP trials are running smoothly in the US.
It's really a shame the FDA did not allow them to start Phase III for EPP this year.
us trials - good news
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.96 |
Change
-0.200(1.41%) |
Mkt cap ! $699.0M | |||
| Open | High | Low | Value | Volume |
| $14.20 | $14.24 | $13.88 | $631.9K | 44.90K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 416 | $13.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.04 | 192 | 1 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |